Filing Details
- Accession Number:
- 0001225208-20-011289
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-04 14:58:55
- Reporting Period:
- 2020-09-02
- Accepted Time:
- 2020-09-04 14:58:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 200406 | Johnson & Johnson | JNJ | Pharmaceutical Preparations (2834) | 221024240 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1745955 | E Kathryn Wengel | One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933 | Evp, Chief Gsc Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-02 | 8,238 | $62.20 | 66,658 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-09-02 | 7,877 | $65.37 | 74,535 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-02 | 7,877 | $153.51 | 66,658 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-02 | 8,238 | $153.53 | 58,420 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2020-09-02 | 8,238 | $0.00 | 8,238 | $62.20 |
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2020-09-02 | 7,877 | $0.00 | 7,877 | $65.37 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-01-11 | 2021-01-08 | No | 4 | M | Direct |
| 0 | 2015-01-18 | 2022-01-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 35 | Indirect | By 401k |
| Common Stock | 281 | Indirect | By ESOP |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $153.47 to $153.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $153.51 to $153.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2020).
- Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2020).
Billionaire Hedge Funds
